Follow
Francisco J Tinahones
Francisco J Tinahones
Verified email at uma.es
Title
Cited by
Cited by
Year
Canagliflozin and cardiovascular and renal events in type 2 diabetes
B Neal, V Perkovic, KW Mahaffey, D De Zeeuw, G Fulcher, N Erondu, ...
New England Journal of Medicine 377 (7), 644-657, 2017
76092017
Canagliflozin and renal outcomes in type 2 diabetes and nephropathy
V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ...
New England journal of medicine 380 (24), 2295-2306, 2019
48962019
Dapagliflozin in patients with chronic kidney disease
HJL Heerspink, BV Stefánsson, R Correa-Rotter, GM Chertow, T Greene, ...
New England Journal of Medicine 383 (15), 1436-1446, 2020
33832020
Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes
JB Green, MA Bethel, PW Armstrong, JB Buse, SS Engel, J Garg, R Josse, ...
New England Journal of Medicine 373 (3), 232-242, 2015
30892015
Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes
RR Holman, MA Bethel, RJ Mentz, VP Thompson, Y Lokhnygina, JB Buse, ...
New England Journal of Medicine 377 (13), 1228-1239, 2017
19222017
Benefits of polyphenols on gut microbiota and implications in human health
F Cardona, C Andrés-Lacueva, S Tulipani, FJ Tinahones, ...
The Journal of nutritional biochemistry 24 (8), 1415-1422, 2013
16162013
Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
M Husain, AL Birkenfeld, M Donsmark, K Dungan, FG Eliaschewitz, ...
New England Journal of Medicine 381 (9), 841-851, 2019
13332019
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
13162018
Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects
WPT James, ID Caterson, W Coutinho, N Finer, LF Van Gaal, ...
New England Journal of Medicine 363 (10), 905-917, 2010
11902010
Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial
J Rosenstock, V Perkovic, OE Johansen, ME Cooper, SE Kahn, N Marx, ...
Jama 321 (1), 69-79, 2019
10682019
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
JM Moreno-Navarrete, F Ortega, M Serrano, E Guerra, G Pardo, ...
The Journal of Clinical Endocrinology & Metabolism 98 (4), E769-E778, 2013
9382013
Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study
M Murri, I Leiva, JM Gomez-Zumaquero, FJ Tinahones, F Cardona, ...
BMC medicine 11, 1-12, 2013
8542013
Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers
MI Queipo-Ortuño, M Boto-Ordóñez, M Murri, JM Gomez-Zumaquero, ...
The American journal of clinical nutrition 95 (6), 1323-1334, 2012
7652012
Efficacy and safety of degludec versus glargine in type 2 diabetes
SP Marso, DK McGuire, B Zinman, NR Poulter, SS Emerson, TR Pieber, ...
New England Journal of Medicine 377 (8), 723-732, 2017
6872017
Cardiovascular efficacy and safety of bococizumab in high-risk patients
PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ...
New England Journal of Medicine 376 (16), 1527-1539, 2017
6492017
Gut microbiota composition in male rat models under different nutritional status and physical activity and its association with serum leptin and ghrelin levels
MI Queipo-Ortuño, LM Seoane, M Murri, M Pardo, JM Gomez-Zumaquero, ...
PloS one 8 (5), e65465, 2013
5532013
EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study
KK Ray, B Molemans, WM Schoonen, P Giovas, S Bray, G Kiru, J Murphy, ...
European journal of preventive cardiology 28 (11), 1279-1289, 2021
5282021
Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11. 2 locus
S Jacquemont, A Reymond, F Zufferey, L Harewood, RG Walters, ...
Nature 478 (7367), 97-102, 2011
5242011
Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation
P Pérez-Martínez, DP Mikhailidis, VG Athyros, M Bullo, P Couture, ...
Nutrition reviews 75 (5), 307-326, 2017
4202017
New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month …
H Yki-Järvinen, R Bergenstal, M Ziemen, M Wardecki, I Muehlen-Bartmer, ...
Diabetes Care 37 (12), 3235-3243, 2014
3852014
The system can't perform the operation now. Try again later.
Articles 1–20